Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Meningococcal disease.

Andrew J Daley1

  • 1Royal Children's and Royal Women's Hospitals, Melbourne, Victoria. andrew.daley@wch.org.au

Australian Family Physician
|September 17, 2003
PubMed
Summary
This summary is machine-generated.

Invasive meningococcal disease, caused by Neisseria meningitidis, remains a threat despite advances. Early diagnosis and treatment are crucial for managing this common cause of meningitis and septicaemia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Entangled States from Sparsely Coupled Spins for Metrology with Neutral Atoms.

Physical review letters·2025
Same author

Engineered chirality of one-dimensional nanowires.

Science advances·2025
Same author

Microbiology and Management of Neonatal Conjunctivitis Presenting to an Urban Australian Paediatric Hospital: An Eight-Year Retrospective Review.

Clinical & experimental ophthalmology·2025
Same author

An Improved Rapid and Sensitive Long Amplicon Method for Nanopore-Based RSV Whole-Genome Sequencing.

Influenza and other respiratory viruses·2025
Same author

Speeding Up Quantum Measurement Using Space-Time Trade-Off.

Physical review letters·2025
Same author

Genomic interrogation of invasive group A <i>Streptococcus</i> (iGAS) epidemiology and COVID-19 impacts in Victoria, Australia: a 6-year retrospective study.

The Lancet regional health. Western Pacific·2025
Same journal

Occupational violence and staff safety in general practice.

Australian family physician·2018
Same journal

You should get that mole checked out: Ethical and legal considerations of the unsolicited clinical opinion.

Australian family physician·2018
Same journal

Understanding the decision to commence a dose administration aid.

Australian family physician·2018
Same journal

Psychological distress and risky sexual behaviours among women aged 16-25 years in Victoria, Australia.

Australian family physician·2018
Same journal

A mixed-methods feasibility study of routinely weighing patients in general practice to aid weight management.

Australian family physician·2018
Same journal

The Australian Mid-West Coastal Marine Wound Infections Study.

Australian family physician·2018
See all related articles

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Neisseria meningitidis causes invasive meningococcal disease, leading to significant morbidity and mortality.
  • Despite advances in prevention and management, the disease remains a public health concern.

Purpose of the Study:

  • To provide a comprehensive overview of meningococcal disease.
  • To cover etiology, pathogenesis, transmission, epidemiology, clinical presentation, diagnosis, treatment, and prevention.

Main Methods:

  • Literature review and synthesis of current knowledge on Neisseria meningitidis.
  • Epidemiological data analysis and clinical case reviews.
  • Vaccine efficacy and public health policy review.

Main Results:

Related Experiment Videos

  • Neisseria meningitidis is a leading cause of meningitis and septicaemia, especially in young individuals.
  • Early recognition and prompt treatment are critical for patient outcomes.
  • Close contact facilitates disease transmission, necessitating prophylaxis for contacts.

Conclusions:

  • Neisseria meningitidis is a significant pathogen causing meningitis and septicaemia.
  • Effective prevention strategies include vaccination and prompt prophylaxis.
  • The conjugate meningococcal C vaccine is now funded for children and young adults in Australia.